Skeletal Muscle Pathology in Peripheral Artery Disease: A Brief Review.
暂无分享,去创建一个
L. Ferrucci | R. Sufit | M. McDermott | C. Peterson | C. Leeuwenburgh | M. Gonzalez‐Freire | K. Kosmac | Sunil K Saini | C. Peterson | M. Gonzalez-Freire | Kate Kosmac | Luigi Ferrucci | Christiaan Leeuwenburgh
[1] L. Ferrucci,et al. Correlations of Calf Muscle Macrophage Content With Muscle Properties and Walking Performance in Peripheral Artery Disease , 2020, Journal of the American Heart Association.
[2] A. Moore,et al. Associations of Peripheral Artery Disease With Calf Skeletal Muscle Mitochondrial DNA Heteroplasmy , 2020, Journal of the American Heart Association.
[3] S. Ng,et al. Peripheral arterial disease: the role of extracellular volume measurements in lower limb muscles with MRI , 2020, European Radiology.
[4] L. Ferrucci,et al. Cocoa to Improve Walking Performance in Older People With Peripheral Artery Disease , 2020, Circulation research.
[5] L. Ferrucci,et al. Comparing 6-minute walk versus treadmill walking distance as outcomes in randomized trials of peripheral artery disease. , 2019, Journal of vascular surgery.
[6] Y. Mavros,et al. Resistance training as a treatment for older persons with peripheral artery disease: a systematic review and meta-analysis , 2019, British Journal of Sports Medicine.
[7] P. Neufer,et al. Extensive skeletal muscle cell mitochondriopathy distinguishes critical limb ischemia patients from claudicants. , 2018, JCI insight.
[8] R. Richardson,et al. Increased skeletal muscle mitochondrial free radical production in peripheral arterial disease despite preserved mitochondrial respiratory capacity , 2018, Experimental physiology.
[9] L. Ferrucci,et al. Peripheral artery disease, calf skeletal muscle mitochondrial DNA copy number, and functional performance , 2018, Vascular medicine.
[10] E. Hefti,et al. Mitochondrial DNA heteroplasmy in cardiac tissue from individuals with and without coronary artery disease , 2018, Mitochondrial DNA. Part A, DNA mapping, sequencing, and analysis.
[11] R. Youle,et al. Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance , 2018, Current Biology.
[12] M. McDermott,et al. Improving Lower Extremity Functioning in Peripheral Artery Disease: Exercise, Endovascular Revascularization, or Both? , 2017, JAMA.
[13] L. Ferrucci,et al. Walking performance is positively correlated to calf muscle fiber size in peripheral artery disease subjects, but fibers show aberrant mitophagy: an observational study , 2016, Journal of Translational Medicine.
[14] Y. Hellsten,et al. Capillary ultrastructure and mitochondrial volume density in skeletal muscle in relation to reduced exercise capacity of patients with intermittent claudication. , 2016, American journal of physiology. Regulatory, integrative and comparative physiology.
[15] I. Pipinos,et al. Abnormal myofiber morphology and limb dysfunction in claudication. , 2015, The Journal of surgical research.
[16] L. Ferrucci,et al. Unsupervised Exercise and Mobility Loss in Peripheral Artery Disease: A Randomized Controlled Trial , 2015, Journal of the American Heart Association.
[17] I. Pipinos,et al. Abnormal Accumulation of Desmin in Gastrocnemius Myofibers of Patients with Peripheral Artery Disease , 2015, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[18] I. Pipinos,et al. Oxidative damage in the gastrocnemius of patients with peripheral artery disease is myofiber type selective , 2014, Redox biology.
[19] L. Ferrucci,et al. Six-Minute Walk Is a Better Outcome Measure Than Treadmill Walking Tests in Therapeutic Trials of Patients With Peripheral Artery Disease , 2014, Circulation.
[20] P. Westgate,et al. Fibre type‐specific satellite cell response to aerobic training in sedentary adults , 2014, The Journal of physiology.
[21] Igor Rudan,et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis , 2013, The Lancet.
[22] I. Pipinos,et al. Oxidative damage and myofiber degeneration in the gastrocnemius of patients with peripheral arterial disease , 2013, Journal of Translational Medicine.
[23] A. Samal,et al. Morphometric analysis of gastrocnemius muscle biopsies from patients with peripheral arterial disease: objective grading of muscle degeneration. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.
[24] W. Hiatt,et al. A systematic review and meta-analysis of propionyl-l-carnitine effects on exercise performance in patients with claudication , 2013, Vascular medicine.
[25] A. Orekhov,et al. Mitochondrial Mutations are Associated with Atherosclerotic Lesions in the Human Aorta , 2012, Clinical & developmental immunology.
[26] M. McDermott,et al. Clinical correlates of size and number of collateral vessels in peripheral artery disease , 2012, Vascular medicine.
[27] L. Ferrucci,et al. Calf muscle characteristics, strength measures, and mortality in peripheral arterial disease: a longitudinal study. , 2012, Journal of the American College of Cardiology.
[28] Brian H Annex,et al. Alteration in angiogenic and anti-angiogenic forms of vascular endothelial growth factor-A in skeletal muscle of patients with intermittent claudication following exercise training , 2012, Vascular medicine.
[29] C. Meyer,et al. Percutaneous intervention in peripheral artery disease improves calf muscle phosphocreatine recovery kinetics: A pilot study , 2012, Vascular medicine.
[30] Jason D. Allen,et al. Angiogenesis in Skeletal Muscle Precede Improvements in Peak Oxygen Uptake in Peripheral Artery Disease Patients , 2011, Arteriosclerosis, Thrombosis and Vascular Biology.
[31] D. Kuh,et al. Objectively measured physical capability levels and mortality: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.
[32] Mark Stoneking,et al. Detecting heteroplasmy from high-throughput sequencing of complete human mitochondrial DNA genomes. , 2010, American journal of human genetics.
[33] L. Ferrucci,et al. Pathophysiological Changes in Calf Muscle Predict Mobility Loss at 2-Year Follow-Up in Men and Women With Peripheral Arterial Disease , 2009, Circulation.
[34] C. Meyer,et al. Multifactorial determinants of functional capacity in peripheral arterial disease: uncoupling of calf muscle perfusion and metabolism. , 2009, Journal of the American College of Cardiology.
[35] F. Piquard,et al. Contralateral leg as a control during skeletal muscle ischemia-reperfusion. , 2009, The Journal of surgical research.
[36] Luigi Ferrucci,et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. , 2009, JAMA.
[37] I. Pipinos,et al. Chronically ischemic mouse skeletal muscle exhibits myopathy in association with mitochondrial dysfunction and oxidative damage. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.
[38] L. Ferrucci,et al. Associations Between Lower Extremity Ischemia, Upper and Lower Extremity Strength, and Functional Impairment with Peripheral Arterial Disease , 2008, Journal of the American Geriatrics Society.
[39] L. Ferrucci,et al. Elevated levels of inflammation, d-dimer, and homocysteine are associated with adverse calf muscle characteristics and reduced calf strength in peripheral arterial disease. , 2007, Journal of the American College of Cardiology.
[40] M. Hesselink,et al. Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD , 2007, European Respiratory Journal.
[41] L. Ferrucci,et al. Lower Extremity Ischemia, Calf Skeletal Muscle Characteristics, and Functional Impairment in Peripheral Arterial Disease , 2007, Journal of the American Geriatrics Society.
[42] D. Baker,et al. Increased angiogenic response but deficient arteriolization and abnormal microvessel ultrastructure in critical leg ischaemia , 2006, The British journal of surgery.
[43] I. Pipinos,et al. Mitochondrial defects and oxidative damage in patients with peripheral arterial disease. , 2006, Free radical biology & medicine.
[44] Andrew D. Williams,et al. Skeletal muscle phenotype is associated with exercise tolerance in patients with peripheral arterial disease. , 2005, Journal of vascular surgery.
[45] Luigi Ferrucci,et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. , 2004, JAMA.
[46] J. Guralnik,et al. The Ankle Brachial Index Is Associated with Leg Function and Physical Activity: The Walking and Leg Circulation Study , 2002, Annals of Internal Medicine.
[47] P. Walker,et al. Skeletal muscle mitochondrial ATP production rate and walking performance in peripheral arterial disease , 2002, Clinical physiology and functional imaging.
[48] R. Newton,et al. Muscle fiber characteristics in patients with peripheral arterial disease. , 2001, Medicine and science in sports and exercise.
[49] R. Newton,et al. Resistance training in patients with peripheral arterial disease: effects on myosin isoforms, fiber type distribution, and capillary supply to skeletal muscle. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.
[50] Hong Wang,et al. Multiple skeletal muscle mitochondrial DNA deletions in patients with unilateral peripheral arterial disease , 2000, Vascular medicine.
[51] I. Pipinos,et al. Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle. , 2000, Journal of vascular surgery.
[52] F. Maltais,et al. Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD. , 1999, The European respiratory journal.
[53] F. Maltais,et al. Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. , 1998, Journal of cardiopulmonary rehabilitation.
[54] F. Maltais,et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. , 1998, Medicine and science in sports and exercise.
[55] J. Regensteiner,et al. Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease. , 1996, Journal of applied physiology.
[56] J. Regensteiner,et al. Muscle denervation in peripheral arterial disease , 1992, Neurology.
[57] D. Pette,et al. Molecular basis of the phenotypic characteristics of mammalian muscle fibres. , 1988, Ciba Foundation symposium.
[58] K. Angquist,et al. Peripheral arterial insufficiency and the fine structure of the gastrocnemius muscle. , 1988, International angiology : a journal of the International Union of Angiology.
[59] K. Angquist,et al. Intermittent claudication and muscle fiber fine structure: correlation between clinical and morphological data. , 1980, Ultrastructural pathology.